Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Metropolis Healthcare Ltd.
Change Company   
BSE Code 542650
ISIN Demat INE112L01020
Book Value 262.36
NSE Code METROPOLIS
Dividend Yield % 0.00
Market Cap 102850.12
P/E 74.48
EPS 26.64
Face Value 2  
31-Jan-2026 Metropolis Healthcare informs about board meeting
13-Jan-2026 Metropolis Healthcare launches Centre of Genomics
13-Jan-2026 Metropolis Healthcare informs about press release
13-Jan-2026 Metropolis Healthcare rises on launching Centre o...
05-Jan-2026 Metropolis Healthcare informs about updates
04-Nov-2025 Metropolis Healthcare informs about grant of stoc...
19-Sep-2025 Metropolis Healthcare acquires Ambika Pathology i...
19-Sep-2025 Metropolis Healthcare shines on acquiring Ambika ...
16-Sep-2025 Metropolis Healthcare incorporates wholly owned s...
02-Jul-2025 Metropolis Healthcare informs about disclosure
18-Jun-2025 Metropolis Healthcare rises as its arm acquires e...
17-Jun-2025 Metropolis Healthcare’s arm acquires entire busin...
17-Jun-2025 Metropolis Healthcare informs about updates on ac...
31-May-2025 Metropolis Healthcare submits analyst meet intima...
24-May-2025 Metropolis Healthcare informs about disclosure
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.